Observational studyDrug design, development and therapy2025

Dose Optimization of Rivaroxaban in Elderly Chinese Patients with Non-Valvular Atrial Fibrillation: Analysis of Populations Pharmacokinetics and Exposure-Response Relationships.

Tian-Yu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.